News
-
Showcasing Impactful Research in Personalised Medicine: The PARADISE project
EP PerMed has published its first success story of impactful research and collaborations in personalised medicine. The PARADISE project aims to develop a deployable, personalised predictive tool that accurately assesses an individual’s immune system activation. By tailoring medication dosages, PARADISE aims to redefine the way autoimmune diseases are managed, significantly improving patient care and quality of life.
-
Success Stories for African-European Collaboration in Personalised Medicine published
EU-Africa PerMed, a project of the ICPerMed Family, has identified and is showcasing success stories of African-European research collaborations in personalised medicine.
-
Guidelines for Design and Implementation of Personalised Medicine Research
The PERMIT project has unveiled a comprehensive set of methodological recommendations designed to enhance the quality and impact of PM research at every stage of the pipeline.
EP PerMed JTC 2025
#PGxPM2025
With its second Joint Transnational Call (JTC), EP PerMed aims to fund human health research on pharmacogenomic strategies for personalised medicine approaches. The deadline for submission of pre-proposals is 18 February 2025. Funding decisions are expected to be communicated in October 2025.
EP PerMed Conference2025
EP PerMed will organise its first EP PerMed Conference on Personalised Medicine Research on 11 and 12 February 2025 in Berlin (Germany), followed by a Training Workshop on Scientific Integrity on 12 and 13 February.
Mission & Objectives
The vision of the European Partnership for Personalised Medicine is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society.
Dr. Wolfgang Ballensiefen, Coordinator
Governance & Boards
The European Partnership for Personalised Medicine gathers together more than 50 partners from over 20 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.